Ibrutinib Exerts Potent Antifibrotic and Antitumor Activities in Mouse Models of Pancreatic Adenocarcinoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Ibrutinib Exerts Potent Antifibrotic and Antitumor Activities in Mouse Models of Pancreatic Adenocarcinoma

Published:2015-04-14 Issue:8 Volume:75 Page:1675-1681
ISSN:0008-5472
Container-title:Cancer Research
language:en
Short-container-title:Cancer Res

Author:

Massó-Vallés Daniel,Jauset Toni,Serrano Erika,Sodir Nicole M.,Pedersen Kim,Affara Nesrine I.,Whitfield Jonathan R.,Beaulieu Marie-Eve,Evan Gerard I.,Elias Laurence,Arribas Joaquín,Soucek Laura

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nanoformulation of dasatinib cannot overcome therapy resistance of pancreatic cancer cells with low LYN kinase expression;Pharmacological Reports;2024-05-13

2. The more the merrier? Evidence and efficacy of immune checkpoint- and tyrosine kinase inhibitor combinations in advanced solid cancers;Cancer Treatment Reviews;2024-04

3. Reprogramming the pancreatic cancer stroma and immune landscape by a silicasome nanocarrier delivering nintedanib, a protein tyrosine kinase inhibitor;Nano Today;2024-02

4. Current trends and future prospects of drug repositioning in gastrointestinal oncology;Frontiers in Pharmacology;2024-01-04

5. Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study;BMC Cancer;2023-11-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP